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Abstract

Diabetic Ketoacidosis is a life-threatening side effect to Diabetes Mellitus. Standards of
treatment and recommendations are made by the American Diabetes Association. The project
was to evaluate and provide the latest evidence-based practice to update the hospital policy for
the treatment of DKA in the Intensive Care Unit and Emergency Department. Retrospective
chart reviews were conducted to review the number of patients admitted with diabetic
ketoacidosis and treated on the DKA Insulin Infusion Protocol before and after the update.
Rapid correction of blood glucose levels proved to be an issue at this facility both before and
after the updates were made to the DKA Insulin Infusion Protocol. The data supports the need
for change in protocol, staff development in the use of the protocol and the need for change in
the emergency department as well as the intensive care unit.

Keywords: Insulin Protocol, DKA, Diabetic Ketoacidosis treatment, Diabetic emergencies, and
glucose monitoring
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SECTION ONE: INTRODUCTION

Diabetic Ketoacidosis (DKA) can be a life-threatening emergency in both the diagnosed
and undiagnosed patients with diabetes. The American Diabetes Association (ADA) makes
recommendations on the treatment of diabetes mellitus as well as treatment of DKA. The ADA
has established protocols and algorithms for the treatment of DKA.
The site of this project is Fauquier Health, which is a Life Point Hospital, located in
Northern Virginia (Fauquier Health, 2018). Fauquier Health treats adult patients with DKA in
the emergency department (ED) and intensive care unit (ICU) using an Insulin Infusion Protocol.
This protocol was developed in 2014 and needs updates based on the latest recommendations by
the ADA, as well as evidence-based research on the subject. Fauquier Health’s mission is to
make the community healthier (Fauquier Health, 2018). Their vision is to create places where
people choose to receive healthcare and where both physicians and employees want to work
(Fauquier Health, 2018). Additionally, their values include the delivery of high quality care,
support of the physicians and employees, fiscal responsibility and leadership in the community
(Fauquier Health, 2018).
Members of the department of nursing, emergency department staff and intensive care
unit staff, as well as the informatics physician, felt there was a need to update the current DKA
Insulin Infusion Protocol with the latest recommendations by the ADA as well as with evidencebased practice. This scholarly project examined the latest research and recommendations for the
treatment of adult’s age 18-75 who are admitted with DKA and treated with Insulin Infusion
Protocols.
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Problem Statement
At Fauquier Health, when an adult patients are admitted with a diagnosis of DKA, they
are treated with an outdated Insulin Infusion Protocol. A possible complication of the use of this
protocol is rapid correction that can lead to further complications such as signs or symptoms of
hypoglycemia. Additionally, the process regarding the measurement of blood glucose by the
nursing staff in the ICU and respiratory therapy as the policy states was in question. To reduce
these possible complications, a review of the protocol and the most recent research was
examined.
Purpose of the Project
The purpose of this scholarly project was to examine the DKA Insulin Infusion Protocol
being used in the ICU and ED to update the protocol to the most up to date research by the ADA.
A team of health care professionals which included the Informatics Physician, the Director of
Pharmacy, the Director of Acute Care Services and the Clinical Coordinator for the ICU
reviewed the recommendations for updating the protocol and adopted most of the changes.
Afterwards, staff development courses were developed, a poster project for display in both the
ICU and ED was presented by the DNP student. In order to improve adherence to the policy, it
is important to educate the stakeholders when treating critically ill patients.
Clinical Question
The use of the current protocol for adult patients with the DKA insulin infusion at
Fauquier Health has led to several patients who were rapidly corrected leading to complications
of hypoglycemia. Concern was expressed that blood glucose monitoring in the ICU is not being
followed per the protocol by the nursing staff and respiratory therapy staff. The protocol needed

SCHOLARLY PROJECT

11

updating with evidence-based practice. Can a change of the Insulin Infusion protocol reduce the
incidence of complications due to rapid correction of blood glucose in the adult DKA patient?
SECTION TWO: LITERATURE REVIEW
Search Strategy
A systematic search was conducted for peer-reviewed journals published within the last
three to five years using the following: CINAHL, EBSCO, Up-to-date and MEDLINE. This
search included the following keywords: Insulin Protocol, DKA, Diabetic Ketoacidosis
treatment, Diabetic emergencies, and glucose monitoring. The search revealed multiple articles
and peer reviewed journals on the subject. Articles were then reviewed and further scrutinized
for relevance ending with 13 articles for review. They were evaluated using Melnyk Levels of
Evidence which revealed two level I, two level II, one level III, two level IV, three level V and
two level VII (Melnyk & Fineout-Overholt, 2015).
Review of Literature
Clain, Ramar, and Surani (2015) reviewed 11 major randomized controlled trials (RCT)
which investigated the use of intensive insulin therapy and conventional insulin therapy. After
reviewing these studies, the authors concluded that the insulin therapies varied greatly, and there
was no clear evidence to support one over another (Clain, Ramar, & Surani, 2015). Tran, et al.
(2017) completed a review of DKA management protocols to examine strengths or weaknesses
of such protocols. The authors found major deficiencies among the evidence for optimal
management of DKA (Tran, et al., 2017). The deficiencies included a lack of timing of
initiation, titration of IV fluids and replacement of electrolytes. They concluded that further
studies were needed as well as the need to include robust evidence-based practices to improve
patient outcomes (Tran, et al., 2017).
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Wilinska and Hovorka (2014) evaluated three established glucose control protocols for
the treatment of DKA. The protocols were tested on 56 virtual patients (Wilinska & Hovorka,
2014). When the authors compared continuous glucose monitoring and hourly blood glucose
level monitoring, the three glucose control protocols varied in effectiveness. The authors
reviewed management of blood glucose levels in hospitalized patients, which requires a team
approach, requires education of all multidisciplinary team members, and careful implementation
and use of standardized protocols (Mackey & Whitaker, 2015). Patients with diabetes can
present the health care providers with challenges to keep glycemic control, especially those who
are critically ill. Mackey and Whitaker (2015) observed some of these challenges as the
pharmacodynamics of insulin, types of insulin used and delivery of insulin. Oral agents would
not be given to critically ill individuals, which leaves insulin preparations and administration by
subcutaneous, basil-bolus, bolus insulin and correction therapy (Mackey & Whitaker, 2015).
Correction insulin therapy can be added to other fluids and can be used intravenously as an
insulin infusion. Regardless of the method used, the authors stressed the importance of
institutional guidelines being used to control blood glucose levels in hospitalized patients
(Mackey & Whitaker, 2015).
The creation of an insulin infusion protocol and best practices is the aim of this scholarly
project. Clergeau et. al (2017) assessed the efficacy, safety and acceptance of insulin protocols
in the ICU. The authors reviewed 131 ICU patients who received continuous intravenous insulin
infusions (dynamic infusion protocols) or sliding scale insulin for management of DKA. The
conclusion included that the dynamic infusion protocols reduced glycemic variability, and
therefore, the risk of patients experiencing hypoglycemic events (Clergeau et al., 2017).
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An examination was conducted of the effectiveness of two different insulin infusion
protocols in a medical intensive care unit using 57 patients (DeBlock et al., 2016). Twenty-two
patients were treated with the Leuven protocol, and 35 patients were treated with the Yale
protocol. The Leuven protocol uses continuous intravenous insulin with a target blood glucose
level between 80 and 100 mg/dl (DeBlock, et al., 2016). The Yale protocol uses intravenous
insulin and a target blood glucose level between 80 and 120 mg/dl (DeBlock, et al., 2016). No
significant differences in the median glycaemia between the two protocols were found (DeBlock
et al., 2016).
A retrospective cohort study was conducted, which evaluated the clinical efficacy and
safety of two types of insulin, human neutral insulin and NovoRapid (insulin aspart) for the
treatment of DKA. Forty patients who had been admitted through the emergency department
with a diagnosis of DKA were reviewed (Kwok et al., 2017). In this study, the authors found a
significant difference in the types of insulin preparations used in the treatment of DKA (Kwok et
al., 2017). However, no significant statistical difference was found to support the use of one type
of insulin over the other (Kwok et al., 2017).
Martin, McKinney, Hoody and Fish (2016) completed a study at a 426-bed hospital to
review treatment outcomes of critical care pathways. Critical care pathways (CCP) used in the
treatment of DKA were reviewed in association of length of stay (LOS) and the authors found a
decrease in LOS with the use of CCP (Martin, et al., 2016). Important factors to consider in the
use of CCP are that it should be mandatory, utilize aggressive IV fluid management and insulin
administration and address the patient’s electrolyte imbalances (Martin, et al., 2016).
An executive committee examined randomized control trials, which examined the
prevalence of diabetes in hospitalized adults (Panikar et al., 2016). Based on the findings the

SCHOLARLY PROJECT

14

executive committee developed an in-hospital protocol for recognizing hyperglycemia (Panikar
et al., 2016). Using a target glucose of 140-180 mg/dl has been shown to reduce the incidence of
hypoglycemia in the critically ill patient on insulin infusion protocols (Soo Hoo, 2015). In the
study by Soo Hoo (2015), the author concluded that the factors, which greatly influenced patient
outcomes, were adherence to policies and guideline.
Transitioning DKA patients from an insulin infusion protocol to subcutaneous insulin can
be a critical piece in the overall favorable outcome of these patients. Kreider and Lien (2015)
completed a literature review on this subject. The authors examined interventions to safely
transition patients from intravenous insulin infusions to subcutaneous insulin and found that no
one protocol worked best for all patients (Krieder & Lien, 2015).
Other situations exist which affect the outcomes of patients admitted in DKA, such as
hypoglycemia, metabolic acidosis and electrolyte imbalances. Brutsaert, Carey and Zonszein
(2014) examined the incidences of hypoglycemia in hospitalized patients. The authors
concluded that there were many gaps in knowledge relating to treatment of hypoglycemia
(Brutsaert, Carey, & Zonszein, 2014). A case report was completed on the deterioration of a
patient in DKA. Consequently, the finding was similar in that the patient had to be rescued
instead of the physicians or nurses recognizing the need for correction of metabolic acidosis and
electrolytes (Van de Vyver, Damen, Haentjens, Ballaux, & Bouts, 2017).
Conceptual Framework
The conceptual framework is the IOWA Model, which will be used as a guide for this
scholarly project. The IOWA Model is a seven-step process, which starts with selection of a
topic and works through a process ending with evaluation (Doody & Doody, 2011). The IOWA
Model is a systematic process, which begins with the identification of the trigger or opportunity

SCHOLARLY PROJECT

15

for change (Zaccagnini & White, 2017). In this scholarly project, the trigger is rapid correction
of blood glucose in patients admitted to Fauquier Health in DKA resulting in adverse reactions.
Once the trigger was identified and the clinical question was developed, the author went through
the steps of the IOWA Model, resulting in the development of evidence, design of a study,
intervention and finally the dissemination of the project (Zaccagnini & White, 2017).
Theoretical Framework
The theoretical framework that will be used for this scholarly project is the Transitional
Care Model. This theory was designed for use on patients who are transitioning from a hospital
setting to home care (Romagnoli, Handler, Ligons, & Hochheiser, 2013). The patients admitted
to Fauquier Health will transition from IV Insulin therapy to subcutaneous insulin as well as
transitioning from intensive care to discharge. Making this transition can be very difficult in
populations of patients newly diagnosed with diabetes or patients who are poorly controlled
diabetics.
SECTION THREE: METHODOLOGY
Design
The design of this scholarly project was a retrospective chart review both 90 days prior to
implementation and 90 days after. Baseline data was compiled regarding the number of adult
patients age 18-75, who were admitted to Fauquier Health in DKA and who were treated with
the Insulin Infusion Protocol. Once it was determined that the patient had a diagnosis of DKA
and they were placed on the Insulin Infusion Protocol, the chart become part of the retrospective
review. After adoption of the updated DKA Insulin Protocol, a second retrospective chart review
was conducted for the first 90 days to compare the data from the first retrospective chart review.
The charts were examined and reviewed for the amount of time from initiation to correction of
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blood glucose if rescue medications had to be given and how the patient tolerated the insulin
infusion.
Measurable Outcomes
The DKA Insulin protocol was updated, which outlines how to manage patients admitted
with diabetes to the ICU from the ED. In addition to the DKA Insulin Infusion protocol update,
an update to the Nursing Guidelines for blood glucose monitoring in the ICU was achieved. This
was based on the data collected which showed the difference between a finger stick blood
glucose level and a random glucose drawn and process in the lab. The decision was made to
change the policy to reflect that patients on the DKA Insulin Infusion Protocol should only have
random glucose levels drawn.
Adult patients who present in DKA, with new onset or chronic diabetes will be properly
managed with the DKA Insulin Protocol; the amount of time and level of blood glucose
correction was monitored which should not exceed 50-70 mg/dl per hour. Additional health care
outcomes measured included the mean time of patients admitted in DKA to reach correction of
electrolyte imbalance and correction of anion gap after the implementation and dissemination of
this updated DKA Insulin Infusion Protocol.
Setting
A for-profit, community hospital in Northern Virginia is the site for this study. This
hospital is licensed for 100 beds. The units monitored included the ICU and ED. The project
aligns with the organization’s mission, values and strategic plan by concentrating on patient care.
Population
This scholarly project included only adult patients age 18-75, admitted to Fauquier
Health in DKA and treated in the ICU or ED, 90 days prior to initiation of the updated DKA
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Insulin Protocol and 90 days afterwards. However, the month of May was excluded completely
due to the initiation of the order set changes without the protocol change implementation. A
total of 15 charts were reviewed for the retrospective review of the 90 days prior to initiation. Of
those 15 charts, three charts were excluded as they were admitted under the correct diagnostic
code although they were never placed on the DKA Insulin Protocol. The sample size for the first
retrospective review was an npre = 11. A total of seven charts were reviewed for the retrospective
review of the 90 days post implementation, of those charts all seven met the inclusion criteria
and were placed on the DKA Insulin Protocol. The sample size for the second retrospective
review was an npost = 6.
Ethical Considerations
Ethical considerations for research on human subjects was strictly enforced. An
Institutional Review Board (IRB) exemption was obtained from the Liberty University IRB. A
letter of support for this scholarly project was obtained from Fauquier Health. Patient privacy
was maintained as outlined by the health insurance portability and accountability act (HIPAA).
All charts reviewed were coded and no patient names or medical record numbers for
identification were used. All correspondence between Fauquier Health and this author have been
sent by encrypted email and the computer is password protected.
Data Collection
Information was collected from charts of patients admitted to ICU from the ED who are
found to be in DKA and were placed on the initial Insulin Infusion Protocol. Data collection for
the 90-day retrospective chart review prior to initiation of the protocol included all patients
admitted in DKA from February 1, 2018 through April 30, 2018. The data for the month of May
was excluded due to a change in the order set used for DKA without the accompanying written
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protocol of the change. The 90-day retrospective chart review of the patients admitted with
DKA and placed on the updated insulin protocol included all patients admitted June 1, 2018
through August 31, 2018. Once adult patients with DKA were identified, the charts were
reviewed for time frame of correction of blood glucose level, and symptoms of hypoglycemia or
other complications post initiation of the DKA Insulin Infusion Protocol.
Tools
A retrospective chart review was completed on all adult patients age 18-75, admitted to
the ICU from the ED in DKA who were placed on the initial DKA Insulin Infusion Protocol.
The original insulin infusion protocol was examined and compared to the latest evidence-based
practice and recommendations by the ADA. The protocol was updated and was distributed for
review and approval. After approval and adoption of the updated protocol was completed, a
second retrospective chart review was completed including patients admitted in DKA from June
1, 2018 through August 31, 2018. All the data collected was then placed in an Excel spreadsheet
to graph the data using time series charts and statistically analyze the findings. In particular,
confidence intervals for important descriptors were given and hypothesis tests were conducted to
examine if there was statistically significant differences between the two protocols.
Data Analysis
Baseline data was collected at the time of inclusion in the retrospective chart review. All
data was then compiled and reviewed for reliability and validity to ensure inclusion criteria was
met. Information was collected through a review of charts for adult patients admitted with DKA
to the ICU from the ED. The charts were reviewed to establish if the patient had any symptoms
of hypoglycemia, were rapidly corrected and had to be given rescue medications after initiation
of the insulin protocol. Patient identifiers were not used as the purpose was to assess whether
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patients rapidly corrected, have symptoms of hypoglycemia, and must be given rescue
medications or exhibit other symptoms after initiation of the insulin infusion protocol only. All
data was then compiled and reviewed for reliability and validity to ensure that all inclusion or
exclusion criteria.
Statistical Analysis
The pre-data showed variability in the correction of blood glucose levels. In table 1, the
patient had evidence which showed rapid correction. In the hours zero to 1:55, the patient’s
glucose level dropped from 1029 mg/dl to 551 mg/dl. In table 2, the patient had evidence which
showed rapid correction. In hour 1:49 to 3:04 the patient’s blood glucose level went from 448
mg/dl to 269 mg/dl. In table 3, evidence exist which shows rapid correction. A drop from 884
mg/dl to 500 mg/dl in 2:21 hours and again from 350 mg/dl to 106 mg/dl in one hour. This is
well outside the recommendation of 50-70 mg/dl/hr by the American Diabetes Association
(Wilinska & Hovorka, 2014). In table 4, the patient went from 510 mg/dl to 430 mg/dl between
hours 3:49 to 4:45. The patient then had another rapid correction between 4:45 to 5:46 where the
patient went from 430 mg/dl to 303 mg/dl. This patient had a third episode of rapid correction
where the patient went from 303 mg/dl to 135 mg/dl in one hour.
In table 5, patient #14 had multiple episodes of rapid correction. In the hours between
zero and 1:14 the patient went from 693 mg/dl to 237 mg/dl. Again at hours 4:30 to 5:32, the
patient dropped from 311 mg/dl to 174 mg/dl.
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Patient #3 Glucose Time Series (mg/dl)
1200
1000
800
600
400
200
0
0

0:50

1:55

2:01

2:55

5:30

7:35

9:05

11:45

Table 1: Pre-data patient #3 Glucose Time Series (mg/dl).

Patient #5 Glucose Time Series (mg/dl)
500
450
400
350
300
250
200
150
100
50
0
0

0:24

0:49

1:49

Table 2: Pre-data patient #5 Glucose Time Series (mg/dl).

3:04

4:24

5:24
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Patient #8 Glucose Time Series (mg/dl)
1000
900
800
700
600
500
400
300
200
100
0

Table 3: Pre-data patient #8 Glucose Time Series.

Patient #11 Glucose Time Series (mg/dl)
700
600
500
400
300
200
100
0
0

0:32

3:35

3:49

4:45

Table 4: Pre-data patient #11 Glucose Time Series (mg/dl).

5:46

6:59

8:05
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Patient #14 Glucose Time Series (mg/dl)
800
700
600
500
400
300
200
100
0
0

1:14

2:13

3:00

3:38

4:26

4:30

5:32

6:34

7:28

Table 5: Pre-data patient #14 Glucose Time Series (mg/dl).
Time to
Correction
(min)

Time to
Correction
(hrs)

739
330
264
2761
3608
1588
485
642
917
332
589

12.32
5.50
4.40
46.02
60.13
26.47
8.08
10.70
15.28
5.53
9.82

Mean
Median
StDev
N
Df

1114.1
642.0
1103.6
11
10

Error
Min
Max

741.37
372.7
1855.5

Pt1
Pt3
Pt5
Pt6
Pt7
Pt8
Pt11
Pt12
Pt13
Pt14
Pt15

Corrected
Value

Drop per
hour
(mg/dl/h)

544
1029
448
747
380
884
616
297
377
693
572

125
332
140
81
166
192
146
139
136
174
250

34.02
126.73
70.00
14.47
3.56
26.15
58.14
14.77
15.77
93.80
32.80

18.57
10.70
18.39
11

598.82
572.00
226.31
11

171.00
146.00
68.33
11

44.56
32.80
38.60
11

12.36
6.2
30.9

152.03
446.8
750.8

45.90
125.1
216.9

25.93
18.6
70.5

Table 6: All pre-data compiled.

High

8:35

9:00

SCHOLARLY PROJECT

23

In table 10, using the pre-protocol data there is 95% confidence that the true mean is
correct. The time to correction was between 6.2 and 30.9 hours. The high glucose concentration
during the time on the insulin infusion protocol was between 446.8 mg/dl and 750.8 mg/dl. The
glucose concentration at the end of the protocol or at correction is between 125.1 mg/dl and
216.9 mg/dl. The glucose concentration reduction per hour is between 18.6 mg/dl/hr and 70.5
mg/dl/hr. However, this is the mean concentration reduction. When each individual patient was
reviewed, this was not the case as some patients were corrected at a much faster rate.
In the post-data, which represents the data obtained from the retrospective chart review
after the DKA Insulin Protocol adoption, there were three episodes of rapid correction. Table 7,
shows that patient #4 had an episode of rapid correction between hour 7:14 and 8:06 of 220
mg/dl to 131 mg/dl. In table 8, the patient had an episode of rapid correction between hour 1:15
and 2:27, of 471 mg/dl to 154 mg/dl. And finally, in table 9, patient #7 had an overall blood
glucose reduction from 959 mg/dl to 140 mg/dl in 6:38 hours. This patient became symptomatic,
and the insulin protocol had to be immediately discontinued.

Post-data Patient #4 Glucose Time Series (mg/dl)
700
600
500
400
300
200
100
0

Table 7: Post-data patient #4 Glucose Times Series (mg/dl).
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Post-data Patient #5 Glucose Times Series (mg/dl)
600
500
400
300
200
100
0
0

1:15 1:25 2:20 2:27 2:57 4:29 4:45 5:38 6:49 7:50 8:30 9:41 10:36 11:30 12:32 13:25 14:27

Table 8: Post-data patient #5 Glucose Times Series (mg/dl).

Post-data Patient #7 Glucose Time Series (mg/dl)
1200
1000
800
600
400
200
0
0

0:36

2:56

4:51

Table 9: Post-data patient #7 Glucose Times Series (mg/dl).

5:24

6:38
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Pt #1
Pt #2
Pt #4
Pt #5
Pt #6
Pt #7
Mean
Median
StDev
N
Df
Error
Min
Max

25

Time to
Correction
(min)

Time to
Correction
(hrs)

High

Corrected
Value

Drop per
hour
(mg/dl/h)

733
778
1259
867
487
398

12.22
12.97
20.98
14.45
8.12
6.63

411
435
579
500
342
959

187
145
141
122
171
140

18.34
22.37
20.87
26.16
21.07
123.47

753.67
755.50
305.56
6
5

12.56
12.59
5.09
6

537.67
467.50
221.59
6

151
143
23.64
6

38.71
21.72
41.60
6

320.72
432.95
1074.38

5.3
7.2
17.9

232.6
305.1
770.3

24.8
126.2
175.8

43.7
-5.0
82.4

Table 10: Post-data compiled.
In table 10, using the post-protocol data there is 95% confidence that the true mean is
correct. The time to correction was between 7.2 and 17.9 hours. The high glucose concentration
during the time on the insulin infusion protocol was between 305.1 mg/dl and 770.3 mg/dl. The
glucose concentration at the end of the protocol or at correction is between 126.2 mg/dl and
216.9 mg/dl. The glucose concentration reduction per hour is between -5.0 mg/dl/hr and 82.4
mg/dl/hr. However, this is the mean concentration reduction. When each individual patient was
reviewed this was not the case.
A two-sample t-test was used on the means for the two protocols for the blood glucose
concentration drop per hour and the time to correction. The hypothesis test was to check if preprotocol change was different from the post-protocol change. The sample sizes were npre = 11
for the pre-protocol change group and the npost = 6 for the post-protocol. The null hypothesis is
the mean time to correction, for pre-protocol is equal to the post-protocol correction. The
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alternate hypothesis is the mean time to concentration is different between the pre-protocol and
post-protocol correction. The alpha= 0.05. The t critical= 3.163381, the test stat= 360.43 and
the standard test= 1.014261. The standard test is not past the critical t-test (positive or negative).
There is not enough evidence to support the claim that the mean time to correction for the two
protocols is different.
The null hypothesis is that the glucose concentration drop per hour is the same for both
the pre-protocol change and the post-protocol change. The alternate hypothesis is that the
glucose concentration drop per hour is different for both the pre-protocol and the post-protocol
change. The α = 0.05. The t critical = 2.48988, the test statistic = 5.85 and the standardized test
statistic = 0.290892.
Feasibility Analysis
This scholarly project was feasible for the organization and in fact was requested by the
organization. This organization saw a trend of patients with DKA who were rapidly being
corrected, and therefore, sought to find the root cause of the problem. Additionally, this along
with many other policies and procedure for this organization were due for updates.
Resources
Outside resources were not needed in order to accomplish this scholarly project. All of
the staff and resources are part of the normal routine for the organization. The only outside
resource used was the printing company for the poster project in order to disseminate the final
outcomes.
Personnel
Those involved in the process of updating the DKA Insulin Infusion Protocol include the
Chief Nursing Officer, the Physician Informaticist, the Director of Acute Care Services, the
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Director of Quality and Safety, the Director of Pharmacy, and the Clinical Coordinator/Educator
Intensive Care Unit. Additional personnel involved include the nursing education department
and the staff for both the ICU and ED.
Technology
The technology which is beneficial to this scholarly project included that the organization
has its own physician Informaticist. He was able to quickly gather the data needed to determine
the number of participants in the retrospective reviews. Once this information was presented to
the DNP student, the charts then had to be manually scrutinized to ensure they met the inclusion
criteria. Electronic Health Record (EHR) technology was also used. Prior to implementation of
the updated DKA Insulin Infusion Protocol, the nurses used paper charting to log the patients’
blood glucose levels and what action was taken. After implementation of the updated protocol, a
new feature was added to the EHR which allows the nurse to chart the time, blood glucose level,
the rate of the insulin infusion and what action was taken. This process has simplified the ability
of health care providers to review the patient’s condition and outcomes.
Significance and/or Implications
Addressing the reason patients admitted in DKA are rapidly corrected, have
hypoglycemic events, or other symptoms after initiation of the insulin infusion protocol benefits
all adult patients admitted with DKA. It is important to use evidence-based practices and the
latest research when updating existing protocols. Nursing practice will be enhanced through
increased knowledge of DKA treatment and favorable patient outcomes.
Evaluation and Dissemination
This author used the evaluability assessment model. This model enables the user to
involve stakeholders in the entire process and can test assumptions and guide its adaptations to
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real-world conditions (Brownson, Colditz, & Proctor, 2012). Discussions were held between the
hospital physicians, the pharmacist, hospital nurse educator and the two clinical directors
regarding the project and the dissemination and implementation. Another aspect of the process
is finding the right venue to present the project (Hanrahan, Marlow, Aldrich, & Hiatt, 2012).
Once the data was collected and analyzed concerning the project’s usefulness, the results were
disseminated to the interdisciplinary staff.
Dissemination of this project’s outcomes were accomplished through distribution of a
poster presentation to colleagues. The use of poster presentations and publications are ways to
contribute and communicate knowledge among nurses and other healthcare professionals
(Hanrahan, Marlow, Aldrich, & Hiatt, 2012). According to Hanrahan, Marlow, Aldrich and
Hiatt (2012), clinical work and evidence-based guidelines are suitable for poster presentation for
dissemination.
Strategies to successfully disseminate and implement this scholarly project include
creating awareness, increasing knowledge and commitment, promoting action and adoption,
pursing integration and sustained use (Iowa Model Collaborative, 2017). Additionally, Moran,
Burson and Conrad (2017), suggests the DNP disseminate their results through verbal
presentations, podium or poster presentations, written submissions to journals and executive
summaries submitted to the organization where the project is intended to be implemented This
can be accomplished in several ways and in several venues. The poster presentation was given
to the ICU and ED as well as becoming part of the nursing department’s staff development.
Recommendations
Fauquier Health is a hospital in Northern Virginia, which has experienced an increased
number of adult patients whose blood glucose is rapidly corrected, suffer hypoglycemic events or
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other symptoms after admission for DKA and the initiation of an insulin infusion protocol. In
the pre-retrospective chart review and post-retrospective chart review, only one patient was
found to have needed rescue medications for a decreased blood glucose level that was
symptomatic. That patient happened to be the last patient in the second retrospective chart
review. However, several patients were shown to have been rapidly corrected, greater than the
recommended 50-70 mg/dl/hr.
The author of this scholarly project has concluded that the next course of action would be
to examine and update the DKA protocol in the ED. Currently the ED uses a protocol which
includes giving insulin via intravenous push. This practice causes the patients to be rapidly
corrected prior to the initiation of the DKA Insulin Infusion Protocol. Further evaluation of both
the ED protocol and ICU protocol is needed to benefit the patients admitted with DKA to this
facility.
Future research is needed to increase favorable patient outcomes. In this scholarly
project the author reviewed the DKA Insulin Infusion Protocol only after its initiation. It would
be beneficial for others in the future to review how the patient is treated from the time of
admission into the ED and until the DKA Insulin Infusion Protocol is initiated.
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6(9), 1082-1091.
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past 15
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glycemic
control in
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intensive
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controlled
trials (RTC)
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the use of
intensive
insulin
therapy or
conventional
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literature.

Methods

Study
Results
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rk)
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treating
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glycemic
control.
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lack of
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studies and
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There are
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of literature
was useful
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eleven of
the top
RCTs and
showed
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Gaal, L. F. (2016). A comparison of
two insulin infusion protocols in the
medical intensive care unit by
continuous glucose monitoring.
Annals of Intensive Care, 6(115), 113.
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insulin
infusion
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medical
intensive
care units.

insulin
therapy in
the intensive
care setting.
131 ICU
patients who
received
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insulin
infusion
management
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57 Medical
Intensive
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patients.
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study
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insulin
protocol
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dynamic
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use in the
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prospectiv
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The authors
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Level V
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The authors
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from an
intravenous
infusion of
insulin to
subcutaneo
us insulin.
Evaluation
of the
clinical
efficacy
and safety
of two
types of
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the
treatment
of diabetic
ketoacidosi
s.
Examinatio
n of the
effectivenes
s of a
critical care
pathway for
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treatment
of diabetic
ketoacidosi
s.

Insulin
protocols
and
transition
protocols.

Literature
Review.

40 patients
who were
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through the
emergency
department
of a tertiary
teaching
hospital with
a diagnosis
of DKA.
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with DKA
who were
coded with
billing codes
250.1 or
250.1x, 387
patients were
included.

The authors
concluded
that further
research is
needed.

Level V

Only
reviewed a
small
sample of
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type of
institution
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No.
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specific
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incidence
of
hypoglyce
mia.

Retrospect The authors
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study
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significant
difference
in the use
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preparation
s in the
treatment of
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Level IV
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sample
size and
study
design
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findings
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a specific
type of
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better
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outcomes.

Retrospect This study
ive chart
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critical care
pathway
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Prior
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limited on
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reviewed a
critical care
pathway
and
implementa
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clinical practice recommendations
for management of in-hospital
hyperglycemia-2016. International
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Developme
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review by
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task force
review of
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Intravenous insulin therapy.
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http://emedicine.medscape.com/artic
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Review of
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RCT to
determine
the best
insulin
infusion
protocol.

NICE
SUGAR
study, 6104
patients.
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Tran, T. T., Pease, A., Wood, A. J., Zajac, J.
D., Bellomo, R., & Ekinci, E. I.
(2017). Review of evidence for adult
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protocols. Frontiers in
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of a single
patient with
rapid
deterioratio
n in DKA.

Single
patient.

Case
report

Wilinska, M. E., & Hovorka, R. (2014).
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unit by use of continuous glucose
monitoring: What level of measurement
error is acceptable? Clinical Chemistry,
60(12), 1500-1509.
http://dx.doi.org/10.1373/clinchem.2014.225
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Evaluation
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glucose
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and
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RCT to be
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improving
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outcomes.
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review not
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reviewed
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review of
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Yes.
Useful to
review how
this patient
was treated
using the
hospital
protocol.
Yes.
Explains
the
differences
between
use of
protocols
and use of
measureme

SCHOLARLY PROJECT PROPOSAL

39
frequency
of glucose
monitoring.

continuous
glucose
monitoring.

nt of
glucose.

SCHOLARLY PROJECT PROPOSAL

40
Appendix B

SCHOLARLY PROJECT PROPOSAL

41
Appendix C

Tuesday, May 8, 2018 at 1:23:09 PM Eastern Daylight Time
Page 1 of 1
Subject: Permission to Use The Iowa Model Revised: Evidence-Based Practice to Promote
Excellence in
Health Care
Date: Thursday, December 28, 2017 at 12:21:04 PM Eastern Standard Time
From: Kimberly Jordan - University of Iowa Hospitals and Clinics
To: Lacey, Susan
You have permission, as requested today, to review and/or reproduce The Iowa Model Revised:
EvidenceBased Prac8ce to Promote Excellence in Health Care. Click the link below to open.
The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health Care
Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted for placing on the
internet.
Citation Iowa Model Collaborative. (2017). Iowa model of evidence-based practice: Revisions and validation.
Worldviews on Evidence-Based Nursing, 14(3), 175-182. doi:10.1111/wvn.12223
In written material, please add the following statement:
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2015. For
permission to use or reproduce, please contact the University of Iowa Hospitals and Clinics at 319-384-9098.
Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions.
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Appendix D

ICU DKA/HHS INSULIN DRIP FLOWSHEET
Start Continuous Infusion

0.1unit/kg/hr.

Subsequent dosing

Based on q1hr accu-check

FSBS not <50-70mg/dl from last hr.

Re-bolus 0.14units/kg IV

FSBS reaches 200mg/dl

Decrease rate to 0.03 units/kg/hr.
* For DKA, maintain this rate until FSBS of 150-200, and DKA resolved
*For HHS, maintain this rate until FSBS of 250-300 until pt. alert and serum
osmolar <315

Subsequent re-bolus dosing

Re-bolus 0.14units/kg/hr. IV if glucose does not fall by 50-70mg/dl from
pervious hour may be necessary

Time/
Date

Blood
glucose

Units/HR
Pt
wt:____kg

FSBS >200 and
not
<50-70 from
last hr.
IV re-bolus
required
@0.14units/kg/hr.

N/A

FSBS
<200

RN signatures

Decrease rate to
0.03units/kg/hr. and
maintain until
DKA/HHS resolved

/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
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June 13, 2018
Susan K. Lacey IRB Exemption 3365.061318: Diabetic Ketoacidosis (DKA) Insulin Infusion
Protocol Update Using Evidence-Based Practice: A Quality Improvement Project
Dear Susan K. Lacey,
The Liberty University Institutional Review Board has reviewed your application in accordance
with the Office for Human Research Protections (OHRP) and Food and Drug
Administration (FDA) regulations and finds your study to be exempt from further IRB
review. This means you may begin your research with the data safeguarding methods
mentioned in your approved application, and no further IRB oversight is required.
Your study falls under exemption category 46.101(b)(4), which identifies specific situations in
which human participants research is exempt from the policy set forth in 45 CFR
46:101(b):
(4) Research involving the collection or study of existing data, documents, records, pathological
specimens, or diagnostic specimens, if these sources are publicly available or if the
information is recorded by the investigator in such a manner that subjects cannot be
identified, directly or through identifiers linked to the subjects.
Please note that this exemption only applies to your current research application, and any
changes to your protocol must be reported to the Liberty IRB for verification of
continued exemption status. You may report these changes by submitting a change in
protocol form or a new application to the IRB and referencing the above IRB Exemption
number.
If you have any questions about this exemption or need assistance in determining whether
possible changes to your protocol would change your exemption status, please email us at
irb@liberty.edu.
Sincerely,
G. Michele Baker, MA, CIP Administrative Chair of Institutional Research The Graduate School

Liberty University | Training Champions for Christ since 1971

